ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $406,000 | -19.1% | 19,549 | -40.5% | 0.01% | -30.0% |
| Q2 2018 | $502,000 | -24.7% | 32,849 | +10.6% | 0.01% | -28.6% |
| Q1 2018 | $667,000 | -25.1% | 29,699 | +0.3% | 0.01% | -26.3% |
| Q4 2017 | $891,000 | -15.8% | 29,599 | +5.4% | 0.02% | -9.5% |
| Q3 2017 | $1,058,000 | +39.6% | 28,091 | +3.3% | 0.02% | +23.5% |
| Q2 2017 | $758,000 | -24.2% | 27,191 | -6.5% | 0.02% | -29.2% |
| Q1 2017 | $1,000,000 | +22.0% | 29,091 | +2.3% | 0.02% | +26.3% |
| Q4 2016 | $820,000 | +5025.0% | 28,450 | +5590.0% | 0.02% | – |
| Q2 2016 | $16,000 | +23.1% | 500 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |